JP2003524392A

JP2003524392A - 遺伝的ワクチンおよび酵素の非確率論的生成

遺伝的ワクチンおよび酵素の非確率論的生成

Info

Publication number: JP2003524392A
Authority: JP; Japan
Prior art keywords: degenerate; cassette; mononucleotide; polynucleotide; optimized
Prior art date: 1999-02-04
Legal status : Pending

Application number

JP2000597406A

Other languages

English (en)

Japanese (ja)

Inventor

ショート、ジェイ、エム．

Original Assignee

ディベルサコーポレーション

Priority date

1999-02-04

Filing date

2000-02-04

Publication date

2003-08-19

2000-02-04 Application filed by ディベルサコーポレーション filed Critical ディベルサコーポレーション

2003-08-19 Publication of JP2003524392A publication Critical patent/JP2003524392A/ja

Status Pending legal-status Critical Current

Links

230000002068 genetic effect Effects 0.000 title claims abstract description 195
229960005486 vaccine Drugs 0.000 title claims abstract description 177
102000004190 Enzymes Human genes 0.000 title abstract description 41
108090000790 Enzymes Proteins 0.000 title abstract description 41
238000000034 method Methods 0.000 claims abstract description 495
102000040430 polynucleotide Human genes 0.000 claims abstract description 417
108091033319 polynucleotide Proteins 0.000 claims abstract description 417
239000002157 polynucleotide Substances 0.000 claims abstract description 417
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 243
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 222
229920001184 polypeptide Polymers 0.000 claims abstract description 209
108090000623 proteins and genes Proteins 0.000 claims abstract description 197
239000013598 vector Substances 0.000 claims abstract description 157
230000028993 immune response Effects 0.000 claims abstract description 132
239000000427 antigen Substances 0.000 claims abstract description 123
108091007433 antigens Proteins 0.000 claims abstract description 122
102000036639 antigens Human genes 0.000 claims abstract description 121
238000002703 mutagenesis Methods 0.000 claims abstract description 78
231100000350 mutagenesis Toxicity 0.000 claims abstract description 76
230000001965 increasing effect Effects 0.000 claims abstract description 75
230000014509 gene expression Effects 0.000 claims abstract description 60
150000007523 nucleic acids Chemical class 0.000 claims description 256
102000039446 nucleic acids Human genes 0.000 claims description 229
108020004707 nucleic acids Proteins 0.000 claims description 229
210000004027 cell Anatomy 0.000 claims description 216
230000035772 mutation Effects 0.000 claims description 85
102000004169 proteins and genes Human genes 0.000 claims description 84
238000012216 screening Methods 0.000 claims description 84
150000001413 amino acids Chemical class 0.000 claims description 72
239000002773 nucleotide Substances 0.000 claims description 58
125000003729 nucleotide group Chemical group 0.000 claims description 57
229910052757 nitrogen Inorganic materials 0.000 claims description 56
108090000695 Cytokines Proteins 0.000 claims description 54
102000004127 Cytokines Human genes 0.000 claims description 53
238000001727 in vivo Methods 0.000 claims description 50
125000003275 alpha amino acid group Chemical group 0.000 claims description 37
102000005962 receptors Human genes 0.000 claims description 37
108020003175 receptors Proteins 0.000 claims description 37
230000001976 improved effect Effects 0.000 claims description 34
239000012634 fragment Substances 0.000 claims description 33
230000000694 effects Effects 0.000 claims description 31
108020004705 Codon Proteins 0.000 claims description 30
108091034117 Oligonucleotide Proteins 0.000 claims description 30
230000001105 regulatory effect Effects 0.000 claims description 28
238000006467 substitution reaction Methods 0.000 claims description 27
238000012360 testing method Methods 0.000 claims description 27
241001465754 Metazoa Species 0.000 claims description 26
210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 26
230000005847 immunogenicity Effects 0.000 claims description 26
230000002519 immonomodulatory effect Effects 0.000 claims description 25
241000282414 Homo sapiens Species 0.000 claims description 23
238000004519 manufacturing process Methods 0.000 claims description 23
241001515965 unidentified phage Species 0.000 claims description 21
239000003446 ligand Substances 0.000 claims description 18
238000005457 optimization Methods 0.000 claims description 18
241000124008 Mammalia Species 0.000 claims description 17
230000001939 inductive effect Effects 0.000 claims description 17
230000000897 modulatory effect Effects 0.000 claims description 17
238000003259 recombinant expression Methods 0.000 claims description 17
230000032258 transport Effects 0.000 claims description 17
230000000295 complement effect Effects 0.000 claims description 16
239000002253 acid Substances 0.000 claims description 15
230000003321 amplification Effects 0.000 claims description 14
238000006243 chemical reaction Methods 0.000 claims description 14
238000003199 nucleic acid amplification method Methods 0.000 claims description 14
230000002829 reductive effect Effects 0.000 claims description 14
210000004962 mammalian cell Anatomy 0.000 claims description 13
230000002163 immunogen Effects 0.000 claims description 12
210000001744 T-lymphocyte Anatomy 0.000 claims description 11
241000700605 Viruses Species 0.000 claims description 11
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 11
239000005557 antagonist Substances 0.000 claims description 10
230000010076 replication Effects 0.000 claims description 10
210000003719 b-lymphocyte Anatomy 0.000 claims description 9
230000001404 mediated effect Effects 0.000 claims description 9
102000003675 cytokine receptors Human genes 0.000 claims description 8
108010057085 cytokine receptors Proteins 0.000 claims description 8
230000004927 fusion Effects 0.000 claims description 8
230000003505 mutagenic effect Effects 0.000 claims description 8
238000000137 annealing Methods 0.000 claims description 7
230000024245 cell differentiation Effects 0.000 claims description 7
102000013462 Interleukin-12 Human genes 0.000 claims description 6
108010065805 Interleukin-12 Proteins 0.000 claims description 6
230000002950 deficient Effects 0.000 claims description 6
230000004069 differentiation Effects 0.000 claims description 6
231100000219 mutagenic Toxicity 0.000 claims description 6
-1 IL-14 Proteins 0.000 claims description 5
102000003814 Interleukin-10 Human genes 0.000 claims description 5
108090000174 Interleukin-10 Proteins 0.000 claims description 5
108010002350 Interleukin-2 Proteins 0.000 claims description 5
102000000588 Interleukin-2 Human genes 0.000 claims description 5
102000004388 Interleukin-4 Human genes 0.000 claims description 5
108090000978 Interleukin-4 Proteins 0.000 claims description 5
229910052799 carbon Inorganic materials 0.000 claims description 5
230000001413 cellular effect Effects 0.000 claims description 5
239000003623 enhancer Substances 0.000 claims description 5
101150013553 CD40 gene Proteins 0.000 claims description 4
102100032937 CD40 ligand Human genes 0.000 claims description 4
241000196324 Embryophyta Species 0.000 claims description 4
108090000176 Interleukin-13 Proteins 0.000 claims description 4
102000003816 Interleukin-13 Human genes 0.000 claims description 4
108010002616 Interleukin-5 Proteins 0.000 claims description 4
102000000743 Interleukin-5 Human genes 0.000 claims description 4
108091092195 Intron Proteins 0.000 claims description 4
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 4
239000000556 agonist Substances 0.000 claims description 4
230000033228 biological regulation Effects 0.000 claims description 4
230000008859 change Effects 0.000 claims description 4
230000000139 costimulatory effect Effects 0.000 claims description 4
230000003247 decreasing effect Effects 0.000 claims description 4
229940117681 interleukin-12 Drugs 0.000 claims description 4
238000003860 storage Methods 0.000 claims description 4
206010020751 Hypersensitivity Diseases 0.000 claims description 3
108010050904 Interferons Proteins 0.000 claims description 3
102000014150 Interferons Human genes 0.000 claims description 3
108010076504 Protein Sorting Signals Proteins 0.000 claims description 3
230000007423 decrease Effects 0.000 claims description 3
230000002401 inhibitory effect Effects 0.000 claims description 3
230000008488 polyadenylation Effects 0.000 claims description 3
230000009467 reduction Effects 0.000 claims description 3
230000002194 synthesizing effect Effects 0.000 claims description 3
241000894006 Bacteria Species 0.000 claims description 2
101000868215 Homo sapiens CD40 ligand Proteins 0.000 claims description 2
108090000708 Proteasome Endopeptidase Complex Proteins 0.000 claims description 2
102000004245 Proteasome Endopeptidase Complex Human genes 0.000 claims description 2
230000000973 chemotherapeutic effect Effects 0.000 claims description 2
230000008030 elimination Effects 0.000 claims description 2
238000003379 elimination reaction Methods 0.000 claims description 2
230000001747 exhibiting effect Effects 0.000 claims description 2
239000000430 cytokine receptor antagonist Substances 0.000 claims 3
102000009410 Chemokine receptor Human genes 0.000 claims 2
108050000299 Chemokine receptor Proteins 0.000 claims 2
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 2
108010002352 Interleukin-1 Proteins 0.000 claims 2
102000000589 Interleukin-1 Human genes 0.000 claims 2
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 2
108090000237 interleukin-24 Proteins 0.000 claims 2
102000003898 interleukin-24 Human genes 0.000 claims 2
102100025074 C-C chemokine receptor-like 2 Human genes 0.000 claims 1
102000008203 CTLA-4 Antigen Human genes 0.000 claims 1
108010021064 CTLA-4 Antigen Proteins 0.000 claims 1
229940045513 CTLA4 antagonist Drugs 0.000 claims 1
241000206602 Eukaryota Species 0.000 claims 1
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 claims 1
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 1
102000004551 Interleukin-10 Receptors Human genes 0.000 claims 1
108010017550 Interleukin-10 Receptors Proteins 0.000 claims 1
108090000177 Interleukin-11 Proteins 0.000 claims 1
102000013691 Interleukin-17 Human genes 0.000 claims 1
108050003558 Interleukin-17 Proteins 0.000 claims 1
102000003810 Interleukin-18 Human genes 0.000 claims 1
108090000171 Interleukin-18 Proteins 0.000 claims 1
108010002386 Interleukin-3 Proteins 0.000 claims 1
108090001005 Interleukin-6 Proteins 0.000 claims 1
108090001007 Interleukin-8 Proteins 0.000 claims 1
108010002335 Interleukin-9 Proteins 0.000 claims 1
241000209510 Liliopsida Species 0.000 claims 1
230000006052 T cell proliferation Effects 0.000 claims 1
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 1
108091023040 Transcription factor Proteins 0.000 claims 1
208000030961 allergic reaction Diseases 0.000 claims 1
230000003190 augmentative effect Effects 0.000 claims 1
230000004663 cell proliferation Effects 0.000 claims 1
230000021615 conjugation Effects 0.000 claims 1
230000006378 damage Effects 0.000 claims 1
235000019621 digestibility Nutrition 0.000 claims 1
241001233957 eudicotyledons Species 0.000 claims 1
208000002672 hepatitis B Diseases 0.000 claims 1
229940079322 interferon Drugs 0.000 claims 1
108040006852 interleukin-4 receptor activity proteins Proteins 0.000 claims 1
108091005485 macrophage scavenger receptors Proteins 0.000 claims 1
102000014452 scavenger receptors Human genes 0.000 claims 1
230000003834 intracellular effect Effects 0.000 abstract description 7
230000004071 biological effect Effects 0.000 abstract description 6
239000003242 anti bacterial agent Substances 0.000 abstract description 3
229940088710 antibiotic agent Drugs 0.000 abstract description 3
230000000704 physical effect Effects 0.000 abstract description 2
238000002651 drug therapy Methods 0.000 abstract 1
230000009261 transgenic effect Effects 0.000 abstract 1
235000018102 proteins Nutrition 0.000 description 79
235000001014 amino acid Nutrition 0.000 description 59
238000009739 binding Methods 0.000 description 57
230000027455 binding Effects 0.000 description 56
108020004414 DNA Proteins 0.000 description 55
238000000338 in vitro Methods 0.000 description 48
229940024606 amino acid Drugs 0.000 description 46
238000003752 polymerase chain reaction Methods 0.000 description 41
229940088598 enzyme Drugs 0.000 description 38
241000894007 species Species 0.000 description 38
210000000612 antigen-presenting cell Anatomy 0.000 description 28
230000015572 biosynthetic process Effects 0.000 description 27
239000000047 product Substances 0.000 description 27
230000006798 recombination Effects 0.000 description 27
238000005215 recombination Methods 0.000 description 27
239000000758 substrate Substances 0.000 description 27
108091028043 Nucleic acid sequence Proteins 0.000 description 26
239000004698 Polyethylene Substances 0.000 description 26
230000008569 process Effects 0.000 description 25
230000000890 antigenic effect Effects 0.000 description 24
238000003786 synthesis reaction Methods 0.000 description 23
239000000203 mixture Substances 0.000 description 22
238000013459 approach Methods 0.000 description 21
239000000523 sample Substances 0.000 description 21
244000052769 pathogen Species 0.000 description 20
239000003981 vehicle Substances 0.000 description 20
210000001519 tissue Anatomy 0.000 description 19
229940124856 vaccine component Drugs 0.000 description 19
201000010099 disease Diseases 0.000 description 18
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
238000009396 hybridization Methods 0.000 description 18
238000004422 calculation algorithm Methods 0.000 description 17
230000006870 function Effects 0.000 description 17
230000001717 pathogenic effect Effects 0.000 description 17
230000000670 limiting effect Effects 0.000 description 16
208000015181 infectious disease Diseases 0.000 description 15
230000003053 immunization Effects 0.000 description 14
238000002649 immunization Methods 0.000 description 14
230000009870 specific binding Effects 0.000 description 14
238000011282 treatment Methods 0.000 description 14
108091026890 Coding region Proteins 0.000 description 13
238000012217 deletion Methods 0.000 description 13
230000037430 deletion Effects 0.000 description 13
230000003993 interaction Effects 0.000 description 13
230000037361 pathway Effects 0.000 description 13
230000035897 transcription Effects 0.000 description 13
238000013518 transcription Methods 0.000 description 13
150000007513 acids Chemical class 0.000 description 12
201000004792 malaria Diseases 0.000 description 12
239000013612 plasmid Substances 0.000 description 12
150000001875 compounds Chemical class 0.000 description 11
230000007246 mechanism Effects 0.000 description 11
108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
241000223960 Plasmodium falciparum Species 0.000 description 10
238000011161 development Methods 0.000 description 10
230000018109 developmental process Effects 0.000 description 10
230000006872 improvement Effects 0.000 description 10
239000003471 mutagenic agent Substances 0.000 description 10
239000013615 primer Substances 0.000 description 10
239000000126 substance Substances 0.000 description 10
239000000304 virulence factor Substances 0.000 description 10
230000007923 virulence factor Effects 0.000 description 10
108060003951 Immunoglobulin Proteins 0.000 description 9
101710198693 Invasin Proteins 0.000 description 9
108091007494 Nucleic acid- binding domains Proteins 0.000 description 9
238000007792 addition Methods 0.000 description 9
238000004458 analytical method Methods 0.000 description 9
210000004369 blood Anatomy 0.000 description 9
239000008280 blood Substances 0.000 description 9
239000003795 chemical substances by application Substances 0.000 description 9
238000003776 cleavage reaction Methods 0.000 description 9
102000018358 immunoglobulin Human genes 0.000 description 9
239000003112 inhibitor Substances 0.000 description 9
230000004048 modification Effects 0.000 description 9
238000012986 modification Methods 0.000 description 9
244000045947 parasite Species 0.000 description 9
108091008146 restriction endonucleases Proteins 0.000 description 9
230000007017 scission Effects 0.000 description 9
108010011619 6-Phytase Proteins 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
230000030741 antigen processing and presentation Effects 0.000 description 8
230000001580 bacterial effect Effects 0.000 description 8
230000000875 corresponding effect Effects 0.000 description 8
229940085127 phytase Drugs 0.000 description 8
239000004475 Arginine Substances 0.000 description 7
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 7
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 7
238000001994 activation Methods 0.000 description 7
210000003743 erythrocyte Anatomy 0.000 description 7
102000037865 fusion proteins Human genes 0.000 description 7
108020001507 fusion proteins Proteins 0.000 description 7
210000000987 immune system Anatomy 0.000 description 7
230000036039 immunity Effects 0.000 description 7
230000036961 partial effect Effects 0.000 description 7
230000001681 protective effect Effects 0.000 description 7
210000003491 skin Anatomy 0.000 description 7
238000002255 vaccination Methods 0.000 description 7
241000282693 Cercopithecidae Species 0.000 description 6
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 6
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
241000699670 Mus sp. Species 0.000 description 6
230000004913 activation Effects 0.000 description 6
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
235000009697 arginine Nutrition 0.000 description 6
230000008901 benefit Effects 0.000 description 6
239000002299 complementary DNA Substances 0.000 description 6
210000002889 endothelial cell Anatomy 0.000 description 6
230000006698 induction Effects 0.000 description 6
239000003550 marker Substances 0.000 description 6
239000012528 membrane Substances 0.000 description 6
210000004379 membrane Anatomy 0.000 description 6
108020004999 messenger RNA Proteins 0.000 description 6
230000035755 proliferation Effects 0.000 description 6
230000003252 repetitive effect Effects 0.000 description 6
230000009897 systematic effect Effects 0.000 description 6
108010047041 Complementarity Determining Regions Proteins 0.000 description 5
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 5
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 5
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 5
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
108091054437 MHC class I family Proteins 0.000 description 5
101000723939 Mus musculus Transcription factor HIVEP3 Proteins 0.000 description 5
108091005461 Nucleic proteins Proteins 0.000 description 5
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 5
125000000539 amino acid group Chemical group 0.000 description 5
238000012219 cassette mutagenesis Methods 0.000 description 5
238000010367 cloning Methods 0.000 description 5
230000001186 cumulative effect Effects 0.000 description 5
210000004443 dendritic cell Anatomy 0.000 description 5
238000011239 genetic vaccination Methods 0.000 description 5
229960000310 isoleucine Drugs 0.000 description 5
229930182817 methionine Natural products 0.000 description 5
210000000663 muscle cell Anatomy 0.000 description 5
210000004940 nucleus Anatomy 0.000 description 5
230000002265 prevention Effects 0.000 description 5
230000004044 response Effects 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
238000012163 sequencing technique Methods 0.000 description 5
239000007858 starting material Substances 0.000 description 5
238000001890 transfection Methods 0.000 description 5
239000004474 valine Substances 0.000 description 5
101710117290 Aldo-keto reductase family 1 member C4 Proteins 0.000 description 4
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
108010045374 CD36 Antigens Proteins 0.000 description 4
102000053028 CD36 Antigens Human genes 0.000 description 4
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
241000282412 Homo Species 0.000 description 4
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
239000004472 Lysine Substances 0.000 description 4
102000018697 Membrane Proteins Human genes 0.000 description 4
108010052285 Membrane Proteins Proteins 0.000 description 4
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
102100024952 Protein CBFA2T1 Human genes 0.000 description 4
108020004511 Recombinant DNA Proteins 0.000 description 4
235000009582 asparagine Nutrition 0.000 description 4
229960001230 asparagine Drugs 0.000 description 4
230000009286 beneficial effect Effects 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
238000007796 conventional method Methods 0.000 description 4
238000013461 design Methods 0.000 description 4
238000003745 diagnosis Methods 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
230000010502 episomal replication Effects 0.000 description 4
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
239000001963 growth medium Substances 0.000 description 4
210000002865 immune cell Anatomy 0.000 description 4
238000003018 immunoassay Methods 0.000 description 4
239000002955 immunomodulating agent Substances 0.000 description 4
229940121354 immunomodulator Drugs 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
230000010354 integration Effects 0.000 description 4
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 4
150000002632 lipids Chemical class 0.000 description 4
235000018977 lysine Nutrition 0.000 description 4
210000002540 macrophage Anatomy 0.000 description 4
231100000707 mutagenic chemical Toxicity 0.000 description 4
230000004962 physiological condition Effects 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
230000006337 proteolytic cleavage Effects 0.000 description 4
238000002708 random mutagenesis Methods 0.000 description 4
210000003935 rough endoplasmic reticulum Anatomy 0.000 description 4
238000005204 segregation Methods 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
238000010186 staining Methods 0.000 description 4
239000013603 viral vector Substances 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
241000282708 Aotus <primate> Species 0.000 description 3
102000019034 Chemokines Human genes 0.000 description 3
108010012236 Chemokines Proteins 0.000 description 3
WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
239000004471 Glycine Substances 0.000 description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
102000043129 MHC class I family Human genes 0.000 description 3
108091054438 MHC class II family Proteins 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 3
101710160107 Outer membrane protein A Proteins 0.000 description 3
238000012408 PCR amplification Methods 0.000 description 3
208000030852 Parasitic disease Diseases 0.000 description 3
208000037581 Persistent Infection Diseases 0.000 description 3
241000224024 Plasmodium chabaudi Species 0.000 description 3
102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 3
102000002938 Thrombospondin Human genes 0.000 description 3
108060008245 Thrombospondin Proteins 0.000 description 3
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
235000004279 alanine Nutrition 0.000 description 3
235000008206 alpha-amino acids Nutrition 0.000 description 3
230000004075 alteration Effects 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
235000003704 aspartic acid Nutrition 0.000 description 3
238000003556 assay Methods 0.000 description 3
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
239000000872 buffer Substances 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
230000003197 catalytic effect Effects 0.000 description 3
150000001768 cations Chemical class 0.000 description 3
230000002490 cerebral effect Effects 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
239000013599 cloning vector Substances 0.000 description 3
238000010276 construction Methods 0.000 description 3
235000018417 cysteine Nutrition 0.000 description 3
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
210000000805 cytoplasm Anatomy 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
238000001514 detection method Methods 0.000 description 3
230000029087 digestion Effects 0.000 description 3
239000003814 drug Substances 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
235000013922 glutamic acid Nutrition 0.000 description 3
239000004220 glutamic acid Substances 0.000 description 3
230000012010 growth Effects 0.000 description 3
230000003394 haemopoietic effect Effects 0.000 description 3
210000002443 helper t lymphocyte Anatomy 0.000 description 3
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
235000014304 histidine Nutrition 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
230000009545 invasion Effects 0.000 description 3
231100000518 lethal Toxicity 0.000 description 3
230000001665 lethal effect Effects 0.000 description 3
210000001165 lymph node Anatomy 0.000 description 3
230000002934 lysing effect Effects 0.000 description 3
229920002521 macromolecule Polymers 0.000 description 3
230000033607 mismatch repair Effects 0.000 description 3
210000001616 monocyte Anatomy 0.000 description 3
230000001338 necrotic effect Effects 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
230000007170 pathology Effects 0.000 description 3
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
230000003334 potential effect Effects 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
238000000746 purification Methods 0.000 description 3
230000008439 repair process Effects 0.000 description 3
230000003248 secreting effect Effects 0.000 description 3
238000010187 selection method Methods 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
238000002741 site-directed mutagenesis Methods 0.000 description 3
210000004927 skin cell Anatomy 0.000 description 3
210000000952 spleen Anatomy 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
230000008685 targeting Effects 0.000 description 3
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
AWNBSWDIOCXWJW-WTOYTKOKSA-N (2r)-n-[(2s)-1-[[(2s)-1-(2-aminoethylamino)-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-n'-hydroxy-2-(2-methylpropyl)butanediamide Chemical compound C1=CC=CC2=CC(C[C@H](NC(=O)[C@@H](CC(=O)NO)CC(C)C)C(=O)N[C@@H](C)C(=O)NCCN)=CC=C21 AWNBSWDIOCXWJW-WTOYTKOKSA-N 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 2
108010029697 CD40 Ligand Proteins 0.000 description 2
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
108090000994 Catalytic RNA Proteins 0.000 description 2
102000053642 Catalytic RNA Human genes 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
102000052510 DNA-Binding Proteins Human genes 0.000 description 2
101710096438 DNA-binding protein Proteins 0.000 description 2
108010024212 E-Selectin Proteins 0.000 description 2
102100023471 E-selectin Human genes 0.000 description 2
102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 2
206010061598 Immunodeficiency Diseases 0.000 description 2
102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
102000015696 Interleukins Human genes 0.000 description 2
108010063738 Interleukins Proteins 0.000 description 2
102000043131 MHC class II family Human genes 0.000 description 2
108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
102000011202 Member 2 Subfamily B ATP Binding Cassette Transporter Human genes 0.000 description 2
108010023335 Member 2 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
108020004711 Nucleic Acid Probes Proteins 0.000 description 2
102000057297 Pepsin A Human genes 0.000 description 2
108090000284 Pepsin A Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000007079 Peptide Fragments Human genes 0.000 description 2
108010033276 Peptide Fragments Proteins 0.000 description 2
241000223801 Plasmodium knowlesi Species 0.000 description 2
239000004365 Protease Substances 0.000 description 2
108010029485 Protein Isoforms Proteins 0.000 description 2
102000001708 Protein Isoforms Human genes 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
241000700584 Simplexvirus Species 0.000 description 2
108091081024 Start codon Proteins 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
108010009583 Transforming Growth Factors Proteins 0.000 description 2
102000009618 Transforming Growth Factors Human genes 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 2
102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
230000004520 agglutination Effects 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
239000013566 allergen Substances 0.000 description 2
229960004784 allergens Drugs 0.000 description 2
150000001371 alpha-amino acids Chemical class 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
244000052616 bacterial pathogen Species 0.000 description 2
230000008827 biological function Effects 0.000 description 2
239000012620 biological material Substances 0.000 description 2
230000021164 cell adhesion Effects 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
230000036755 cellular response Effects 0.000 description 2
239000002962 chemical mutagen Substances 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
230000009918 complex formation Effects 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
230000002939 deleterious effect Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
238000010166 immunofluorescence Methods 0.000 description 2
239000012133 immunoprecipitate Substances 0.000 description 2
230000003308 immunostimulating effect Effects 0.000 description 2
230000001771 impaired effect Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
229940047124 interferons Drugs 0.000 description 2
229940047122 interleukins Drugs 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000002510 keratinocyte Anatomy 0.000 description 2
210000001821 langerhans cell Anatomy 0.000 description 2
238000007834 ligase chain reaction Methods 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000035800 maturation Effects 0.000 description 2
238000001823 molecular biology technique Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
239000002736 nonionic surfactant Substances 0.000 description 2
238000007899 nucleic acid hybridization Methods 0.000 description 2
239000002853 nucleic acid probe Substances 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
210000005259 peripheral blood Anatomy 0.000 description 2
239000011886 peripheral blood Substances 0.000 description 2
238000002823 phage display Methods 0.000 description 2
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
210000002729 polyribosome Anatomy 0.000 description 2
239000001103 potassium chloride Substances 0.000 description 2
235000011164 potassium chloride Nutrition 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000001915 proofreading effect Effects 0.000 description 2
235000004252 protein component Nutrition 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
230000007115 recruitment Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
238000012827 research and development Methods 0.000 description 2
108091092562 ribozyme Proteins 0.000 description 2
238000007423 screening assay Methods 0.000 description 2
230000001568 sexual effect Effects 0.000 description 2
230000014639 sexual reproduction Effects 0.000 description 2
230000037432 silent mutation Effects 0.000 description 2
229910001415 sodium ion Inorganic materials 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
230000003637 steroidlike Effects 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
229910052717 sulfur Inorganic materials 0.000 description 2
239000011593 sulfur Substances 0.000 description 2
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
230000005030 transcription termination Effects 0.000 description 2
230000009466 transformation Effects 0.000 description 2
230000014616 translation Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
102000003390 tumor necrosis factor Human genes 0.000 description 2
244000052613 viral pathogen Species 0.000 description 2
230000001018 virulence Effects 0.000 description 2
238000011179 visual inspection Methods 0.000 description 2
238000005406 washing Methods 0.000 description 2
HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 1
BEJKOYIMCGMNRB-GRHHLOCNSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 1
108020005065 3' Flanking Region Proteins 0.000 description 1
108020005029 5' Flanking Region Proteins 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
108091093088 Amplicon Proteins 0.000 description 1
108010032595 Antibody Binding Sites Proteins 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
206010003645 Atopy Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
102100027207 CD27 antigen Human genes 0.000 description 1
241000283707 Capra Species 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
206010063094 Cerebral malaria Diseases 0.000 description 1
CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 1
206010068051 Chimerism Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
108010041986 DNA Vaccines Proteins 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
238000011238 DNA vaccination Methods 0.000 description 1
229940021995 DNA vaccine Drugs 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
101710146739 Enterotoxin Proteins 0.000 description 1
102100033183 Epithelial membrane protein 1 Human genes 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
108700007698 Genetic Terminator Regions Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
101100005713 Homo sapiens CD4 gene Proteins 0.000 description 1
101000850989 Homo sapiens Epithelial membrane protein 1 Proteins 0.000 description 1
101000980827 Homo sapiens T-cell surface glycoprotein CD1a Proteins 0.000 description 1
101000716149 Homo sapiens T-cell surface glycoprotein CD1b Proteins 0.000 description 1
101000716124 Homo sapiens T-cell surface glycoprotein CD1c Proteins 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
241000701806 Human papillomavirus Species 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
102100034349 Integrase Human genes 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
241000222722 Leishmania <genus> Species 0.000 description 1
206010024229 Leprosy Diseases 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
201000009906 Meningitis Diseases 0.000 description 1
206010027280 Meningococcal sepsis Diseases 0.000 description 1
108091061960 Naked DNA Proteins 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
240000009188 Phyllostachys vivax Species 0.000 description 1
108010088113 Plasmodium falciparum erythrocyte membrane protein 1 Proteins 0.000 description 1
241000223819 Plasmodium fragile Species 0.000 description 1
208000020584 Polyploidy Diseases 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
101710194807 Protective antigen Proteins 0.000 description 1
101710086015 RNA ligase Proteins 0.000 description 1
230000004570 RNA-binding Effects 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
101800001707 Spacer peptide Proteins 0.000 description 1
108700005078 Synthetic Genes Proteins 0.000 description 1
108010008038 Synthetic Vaccines Proteins 0.000 description 1
230000006044 T cell activation Effects 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
102100024219 T-cell surface glycoprotein CD1a Human genes 0.000 description 1
102100028082 Tapasin Human genes 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
229910052770 Uranium Inorganic materials 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
241000607734 Yersinia <bacteria> Species 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
102000019997 adhesion receptor Human genes 0.000 description 1
108010013985 adhesion receptor Proteins 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000003862 amino acid derivatives Chemical class 0.000 description 1
238000003277 amino acid sequence analysis Methods 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
230000027645 antigenic variation Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
230000001640 apoptogenic effect Effects 0.000 description 1
229940076005 apoptosis modulator Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
238000002869 basic local alignment search tool Methods 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
238000006065 biodegradation reaction Methods 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
239000000337 buffer salt Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000010366 cell biology technique Methods 0.000 description 1
230000011712 cell development Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000009614 chemical analysis method Methods 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
238000010960 commercial process Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
238000005094 computer simulation Methods 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000001461 cytolytic effect Effects 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000005860 defense response to virus Effects 0.000 description 1
230000022811 deglycosylation Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000000779 depleting effect Effects 0.000 description 1
230000000368 destabilizing effect Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
230000002121 endocytic effect Effects 0.000 description 1
230000012202 endocytosis Effects 0.000 description 1
210000001163 endosome Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
231100000655 enterotoxin Toxicity 0.000 description 1
239000000147 enterotoxin Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
210000003617 erythrocyte membrane Anatomy 0.000 description 1
238000004299 exfoliation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000006260 foam Substances 0.000 description 1
230000007849 functional defect Effects 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
210000004211 gastric acid Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
150000002337 glycosamines Chemical group 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
238000012165 high-throughput sequencing Methods 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
230000004727 humoral immunity Effects 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
125000001841 imino group Chemical group [H]N=* 0.000 description 1
230000007124 immune defense Effects 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
230000002584 immunomodulator Effects 0.000 description 1
230000036046 immunoreaction Effects 0.000 description 1
230000004957 immunoregulator effect Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229910052738 indium Inorganic materials 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
208000000509 infertility Diseases 0.000 description 1
231100000535 infertility Toxicity 0.000 description 1
230000036512 infertility Effects 0.000 description 1
230000004968 inflammatory condition Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000015788 innate immune response Effects 0.000 description 1
239000002919 insect venom Substances 0.000 description 1
230000008611 intercellular interaction Effects 0.000 description 1
229940076144 interleukin-10 Drugs 0.000 description 1
230000031261 interleukin-10 production Effects 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000005304 joining Methods 0.000 description 1
238000011005 laboratory method Methods 0.000 description 1
101150109249 lacI gene Proteins 0.000 description 1
230000003902 lesion Effects 0.000 description 1
231100000225 lethality Toxicity 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
230000002132 lysosomal effect Effects 0.000 description 1
210000003126 m-cell Anatomy 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
230000021121 meiosis Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
108020004084 membrane receptors Proteins 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002736 metal compounds Chemical class 0.000 description 1
230000034778 micropinocytosis Effects 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
210000004925 microvascular endothelial cell Anatomy 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
102000044158 nucleic acid binding protein Human genes 0.000 description 1
108700020942 nucleic acid binding protein Proteins 0.000 description 1
238000006384 oligomerization reaction Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000036281 parasite infection Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
230000003836 peripheral circulation Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
108010088142 pfalhesin Proteins 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
210000004180 plasmocyte Anatomy 0.000 description 1
230000004983 pleiotropic effect Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000002250 progressing effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
230000006916 protein interaction Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000004063 proteosomal degradation Effects 0.000 description 1
239000012264 purified product Substances 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
101150056906 recJ gene Proteins 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
229940124551 recombinant vaccine Drugs 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000032537 response to toxin Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
101150072534 sbcB gene Proteins 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000009919 sequestration Effects 0.000 description 1
230000009131 signaling function Effects 0.000 description 1
238000012868 site-directed mutagenesis technique Methods 0.000 description 1
238000001542 size-exclusion chromatography Methods 0.000 description 1
238000003373 small molecule array Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000011734 sodium Substances 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
239000003270 steroid hormone Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
239000000021 stimulant Substances 0.000 description 1
238000005309 stochastic process Methods 0.000 description 1
239000004575 stone Substances 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
108010059434 tapasin Proteins 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
210000003812 trophozoite Anatomy 0.000 description 1
201000008827 tuberculosis Diseases 0.000 description 1
230000006433 tumor necrosis factor production Effects 0.000 description 1
101150115617 umuC gene Proteins 0.000 description 1
101150046028 umuD gene Proteins 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
210000005166 vasculature Anatomy 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
101150100239 vsr gene Proteins 0.000 description 1
238000001262 western blot Methods 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1